Passive adoptive immunotherapy of low-immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes (Q70230067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Passive adoptive immunotherapy of low-immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

1 October 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334656

1 October 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

1 October 2023

author name string

M. P. Colombo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334656

1 October 2023

I. Arioli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334656

1 October 2023

G. Parmiani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334656

1 October 2023

language of work or name

English

0 references

publication date

1 December 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

15 December 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6334656

full work available at URL

1 October 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910340611

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910340611

1 October 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

International Journal of Cancer

1 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

807-813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of human melanoma growth in nude mice by autologous, alloactivated peripheral blood lymphocytes

9 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 October 2023

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors

1 October 2023

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.

1 October 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

1 October 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

1 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 October 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 October 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization

1 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 October 2023

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

1 October 2023

17

41

361

Old

1981

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.

1 October 2023

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

1 October 2023

Cancer Treatment Reports

21

68

233

Rosenberg

1984

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

1 October 2023

25

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Lysis of tumor biopsy cells by blood lymphocyte subsets of various densities. Autologous and allogeneic studies

1 October 2023

26

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis

1 October 2023

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines

1 October 2023

28

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340611

1 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334656%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference